(CNTX) Context Therapeutics - Performance -64.8% in 12m
CNTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-70.71%
#148 in Peer-Group
Rel. Strength
5.66%
#7241 in Stock-Universe
Total Return 12m
-64.82%
#174 in Peer-Group
Total Return 5y
-87.45%
#154 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 2.66 USD |
| 52 Week Low | 0.55 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 57.17 |
| Buy/Sell Signal +-5 | -0.51 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CNTX (-64.8%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: CNTX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CNTX
| Total Return (including Dividends) | CNTX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 11.28% | 2.14% | 5.25% |
| 3 Months | 6.86% | 0.64% | 24.13% |
| 12 Months | -64.82% | -4.57% | 14.15% |
| 5 Years | -87.45% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | CNTX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 8.6% | 35.8% | 81% |
| 3 Months | -65.2% | -28.5% | 96.9% |
| 12 Months | -92.7% | -74.5% | 44.9% |
| 5 Years | -37.8% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th83.50 | 8.95% | 5.73% |
| 3 Month | %th42.00 | 6.18% | -13.91% |
| 12 Month | %th14.00 | -63.14% | -69.19% |
| 5 Years | %th24.50 | -88.61% | -91.39% |
FAQs
Does Context Therapeutics (CNTX) outperform the market?
No,
over the last 12 months CNTX made -64.82%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months CNTX made 6.86%, while XLV made 0.64%.
Performance Comparison CNTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CNTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.7% | 6% | -50.9% | -79% |
| US NASDAQ 100 | QQQ | -4.5% | 6% | -51.6% | -78% |
| German DAX 40 | DAX | -2.6% | 12.7% | -63.1% | -94% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.6% | 8% | -54.4% | -85% |
| Hongkong Hang Seng | HSI | -4.3% | 5.2% | -70.4% | -103% |
| India NIFTY 50 | INDA | -2.9% | 7.8% | -51.3% | -64% |
| Brasil Bovespa | EWZ | -7.2% | 2.5% | -76% | -75% |
CNTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.4% | 5.4% | -55.1% | -89% |
| Consumer Discretionary | XLY | -4.2% | 8.1% | -43.3% | -83% |
| Consumer Staples | XLP | -5.1% | 10.6% | -52.6% | -74% |
| Energy | XLE | -5.1% | 4.2% | -46.8% | -65% |
| Financial | XLF | -5.4% | 6.2% | -55.9% | -95% |
| Health Care | XLV | -4.2% | 9.1% | -43.6% | -60% |
| Industrial | XLI | -4.8% | 7.1% | -58.8% | -90% |
| Materials | XLB | -7% | 7% | -55.5% | -71% |
| Real Estate | XLRE | -4.7% | 10.3% | -50.7% | -78% |
| Technology | XLK | -5.5% | 2.6% | -53.3% | -76% |
| Utilities | XLU | -3.7% | 9.5% | -54.2% | -88% |
| Aerospace & Defense | XAR | -2.6% | 4.2% | -69.5% | -114% |
| Biotech | XBI | -5.7% | 7.9% | -37.7% | -58% |
| Homebuilder | XHB | -7.2% | 4.3% | -43.8% | -70% |
| Retail | XRT | -7.3% | 6.3% | -46.6% | -76% |
CNTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.6% | 2.84% | -42.6% | -57% |
| Natural Gas | UNG | 4.8% | 21.1% | -34.2% | -63% |
| Gold | GLD | -5% | 12.5% | -71.6% | -104% |
| Silver | SLV | -5.8% | 4.4% | -68.3% | -82% |
| Copper | CPER | -3.8% | 6.7% | -68% | -76% |
CNTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.9% | 10.2% | -47.5% | -63% |
| iShares High Yield Corp. Bond | HYG | -3.5% | 9.7% | -49.8% | -75% |